Marrone Bio Innovations Financials

$4.2 M

Revenue Q3, 2017

$38.6 M

Mkt cap, 16-Feb-2018
Net income (Q3, 2017)(8.5 M)
EBIT (Q3, 2017)(6.6 M)
Cash, 30-Sep-20173.7 M
EV36.5 M

Market Value

Revenue/Financials

Income Statement

Annual

USDFY, 2013Y, 2014FY, 2015FY, 2016

Revenue

14.5 m1.1 m9.8 m14 m

Revenue growth, %

(92%)793%43%

General and administrative expense

18.5 m

Operating expense total

18.5 m

EBIT

(29 m)(15.5 m)(39.5 m)(23.7 m)

EBIT margin, %

(200%)(1416%)(403%)(168%)

Interest expense

6 m669 k2.8 b2.9 m

Interest income

49 k17 k51 m37 m

Pre tax profit

(28.5 m)(16.2 m)(43.7 m)(31.1 m)

Net Income

(28.5 m)(16.2 m)(43.7 m)(31.1 m)

    Quarterly

    USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Revenue

    1.3 m2.8 m3.6 m2.1 m3.4 m2.5 m2.7 m5 m3.6 m4.2 b6.5 b4.2 m

    R&D expense

    4.5 m

    General and administrative expense

    4.5 m6.3 m6 m7.9 m7.4 m5.3 m5.5 m4.5 m3.8 m5.3 b5.1 b5.2 m

    Operating expense total

    8.9 m10.6 m10.3 m11.3 m10.7 m8.8 m7.9 m6.8 m6.4 m7.8 b7.9 b8.3 m

    Depreciation and amortization

    1.5 m

    EBIT

    (8.7 m)(9.5 m)(9.5 m)(11.3 m)(10.4 m)(8.6 m)(7.5 m)(4.9 m)(5.3 m)(5.9 b)(5.4 b)(6.6 m)

    EBIT margin, %

    (645%)(340%)(261%)(547%)(309%)(348%)(279%)(97%)(145%)(142%)(84%)(156%)

    Interest expense

    1.1 m773 k825 k669 k659 k687 k1 m759 k755 k636 m869 m804 k

    Interest income

    24 k10 k11 k9 k6 k14 k15 k10 k8 k1 m

    Pre tax profit

    (6.1 m)(10.2 m)(10.4 m)(11.9 m)(11 m)(9.8 m)(9.3 m)(6.8 m)(7.2 m)(7.6 b)(7.4 b)(8.5 m)

    Net Income

    (6.1 m)(10.2 m)(10.4 m)(11.9 m)(11 m)(9.8 m)(9.3 m)(6.8 m)(7.2 m)(7.6 b)(7.4 b)(8.5 m)

      Balance Sheet

      Annual

      USDFY, 2013FY, 2014FY, 2015FY, 2016

      Cash

      24.5 m35.3 m19.8 m9.6 m

      Accounts Receivable

      6.2 m1.8 m2.3 m3.6 m

      Inventories

      1.7 m1.3 m1.3 m8.5 m

      Current Assets

      58.7 m54.7 m36 m26.9 m

      PP&E

      9.4 m20.2 m18.4 m17.3 m

      Total Assets

      68.9 m77.2 m71.8 m46 m

      Accounts Payable

      4.5 m5.8 m2 m1.4 m

      Current Liabilities

      11.7 m31.2 m12.9 m15.2 m

      Total Liabilities

      76.2 m

      Additional Paid-in Capital

      147.2 m193.1 m201.6 m204.5 m

      Retained Earnings

      (105.4 m)(159.8 m)(203.6 m)(234.6 m)

      Total Equity

      41.8 m33.2 m(2 m)(30.2 m)

      Financial Leverage

      1.6 x2.3 x-35.5 x-1.5 x

        Quarterly

        USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

        Cash

        40.8 m21.3 m57.6 m22.4 m12.2 m27.8 m9.8 m21.2 m16 m1.8 m10.2 m3.7 m

        Accounts Receivable

        2.1 m7.2 m4.1 m2.2 m3 m1.4 m4.7 m4.5 m2.1 m8.1 m5.8 m1.9 m

        Inventories

        10.8 m12.8 m12.5 m11.8 m10.6 m9.8 m8.6 m8 m8.4 m8.1 m8.4 m9.3 m

        Current Assets

        68.6 m47 m80.1 m41.1 m30.2 m43.4 m28.1 m37.8 m30.6 m24.4 m29.6 m19.5 m

        PP&E

        5.7 m15.8 m18.5 m20.1 m20.1 m19.3 m19.1 m18.5 m17.9 m16.9 m16.5 m16.2 m

        Total Assets

        75.4 m63.5 m101 m63.4 m52.5 m80.1 m64 m58.2 m50.2 m43 m47.8 m37.4 m

        Accounts Payable

        5.1 m8.6 m5.2 m4.1 m3.2 m1 m2.6 m2.2 m2.2 m3 m3.2 m2.7 m

        Short-term debt

        1.7 m

        Current Liabilities

        10.2 m14.5 m11.4 m28.6 m27.7 m11.5 m13.4 m13.8 m12.6 m18.6 m21.7 m28.1 m

        Total Debt

        1.7 m

        Total Liabilities

        25 m29.5 m36 m41 m40 m72 m74.7 m74.9 m73.5 m80.2 m83.5 m81.1 m

        Additional Paid-in Capital

        145.9 m149.6 m191.1 m194.2 m195.3 m200.6 m202.2 m202.9 m203.6 m205.1 m214 m214.5 m

        Retained Earnings

        (95.4 m)(115.7 m)(126.1 m)(171.8 m)(182.7 m)(192.5 m)(212.9 m)(219.6 m)(226.8 m)(242.3 m)(249.7 m)(258.2 m)

        Total Equity

        50.4 m34 m65 m22.4 m12.5 m8.1 m(10.7 m)(16.7 m)(23.2 m)(37.2 m)(35.7 m)(43.7 m)

        Financial Leverage

        1.5 x1.9 x1.6 x2.8 x4.2 x9.9 x-6 x-3.5 x-2.2 x-1.2 x-1.3 x-0.9 x

          Cash Flow

          Annual

          USDFY, 2013FY, 2014FY, 2015FY, 2016

          Net Income

          (28.5 m)(16.2 m)(43.7 b)(31.1 m)

          Depreciation and Amortization

          976 k2.2 m

          Accounts Receivable

          (3.4 m)1.8 m(1.2 m)

          Inventories

          (6.8 m)1.3 m582 k

          Accounts Payable

          1.7 m5.8 m(588 k)

          Cash From Operating Activities

          (34 m)(15.5 m)(24.3 m)

          Purchases of PP&E

          (4 m)(209 k)

          Cash From Investing Activities

          (17.7 m)(209 k)

          Long-term Borrowings

          (9.4 m)(260 k)

          Cash From Financing Activities

          66.1 m14.3 m

            Quarterly

            USDQ3, 2013Q1, 2014Q2, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

            Net Income

            (6.1 m)(10.2 m)(10.4 m)(11.9 m)(22.9 m)(32.7 m)(9.3 m)(16.1 m)(23.3 m)(7.6 b)

            Depreciation and Amortization

            833 k1.7 m2.6 m594 k1.2 m1.7 m

            Accounts Receivable

            7.2 m4.1 m(383 k)(1.2 m)398 k(2.3 m)(2.2 m)292 k8.1 m

            Inventories

            869 k2 m2.9 m504 k1.1 m659 k

            Accounts Payable

            8.6 m5.2 m(1.6 m)(2.3 m)(4.4 m)583 k196 k223 k3 m

            Cash From Operating Activities

            (11.4 m)(20.4 m)(28.7 m)(9.7 m)(13.5 m)(18.4 m)

            Purchases of PP&E

            (1 m)(1.4 m)(1.5 m)(49 k)(93 k)(169 k)

            Cash From Investing Activities

            (1 m)(1.4 m)(1.5 m)(49 k)(93 k)(169 k)

            Long-term Borrowings

            (97 k)(192 k)(371 k)(65 k)(129 k)(195 k)

            Cash From Financing Activities

            (589 k)(1.3 m)22.7 m(253 k)14.7 m

              Ratios

              Y, 2017

              EV/EBIT

              -5.5 x

              Financial Leverage

              -0.9 x